FSTL1 and diabetes mellitus: Follistin-like 1 (FSTL1) is considered an adipokine or myokine that has been related to insulin resistance in obese and diabetic patients, producing a pro-inflammatory response [162], although other studies have indicated its cardioprotective effect against ischemic injury [163] and it has been shown that FSTL1 levels are reduced in diabetes patients [164].